噻托溴胺联合呼吸操训练对慢性阻塞性肺疾病患者运动耐力、肺功能及生活质量的影响

张利如1，张王莹 2

（1.西安市西安凤城医院，陕西 西安，710016；2. 西安市未央区第一人民医院，陕西 西安，710016）

浏览次数：78次 下载次数：369次

摘要：

目的 分析噻托溴胺联合呼吸操训练对慢性阻塞性肺疾病（COPD）患者运动耐力、肺功能及生活质量的作用。方法 将我院2014年3月至2016年1月收治的160例COPD患者按入院时间分为观察组与对照组，各80例。对照组给予噻托溴胺药物治疗，观察组给予噻托溴胺药物联合呼吸操训练。对比两组患者的治疗效果。结果 治疗后，两组患者的FEV1% Pred、FVC、PEF、FEV1/FVC、生活质量评分均改善，且观察组患者明显优于对照组（P<0.05）。结论 给予COPD患者噻托溴胺联合呼吸操训练治疗，能够显著提高患者的运动耐力和肺功能，改善生活质量，值得在临床上推广应用。

关键词：噻托溴胺；呼吸操训练；慢性阻塞性肺疾病

中图分类号：R563.9 文献标志码：A文章编号：2096-1413(2017)31-0030-02

Effect of tiotropium bromide combined with respiratory training on exercise tolerance, lung function and quality of life in patients with chronic obstructive pulmonary disease
ZHANG Li-ru 1, ZHANG Ying 2
(1. Xi``an Fengcheng Hospital, Xi``an 710016; 2. Weiyang District First People``s Hospital, Xi``an 710016, China)

ABSTRACT: Objective To investigate the effects of tiotropium bromide combined with respiratory training on exercise tolerance, lung function and quality of life in patients with chronic obstructive pulmonary disease (COPD). Methods A total of 160 patients with COPD in our hospital from March 2014 to January 2016 were divided into observation group and control group according to the admission time, with 80 cases in each group. The control group was treated with tiotropium bromide, while the observation group was given tiotropium bromide combined with respiratory training. The treatment effects were compared between the two groups. Results After treatment, the FEV1% Pred, FVC, PEF, FEV1 /FVC, quality of life scores improved in both groups, and those in the observation group were significantly better than the control group (P<0.05). Conclusion For patients with COPD, the tiotropium bromide combined with respiratory training can significantly improve the patient``s lung function and exercise tolerance, improve the quality of life, which is worthy of clinical application.

KEYWORDS: tiotropium bromide; respiratory training; chronic obstructive pulmonary disease

参考文献：
[1] 卓致远,武焱,张琦,等.噻托溴胺联合呼吸操训练治疗稳定期慢性阻塞性肺病患者的临床研究[J].临床肺科杂志,2016,21(12):2287-2290.
[2] 唐晨.辛伐他汀治疗对慢性阻塞性肺疾病合并肺动脉高压患者心肺功能及炎性细胞因子的影响[J].现代中西医结合杂志,2017,26(8):851-853.
[3] 孙静,杜延玲.慢性阻塞性肺疾病合并肺动脉高压研究进展[J].医 学综述,2014,20(10):1829-1832.
[4] 赵东芳.川芎嗪注射液联合红景天注射液治疗慢性阻塞性肺疾病 合并肺动脉高压疗效观察[J].现代中西医结合杂志,2015,24(31):3435-3437.
[5] 周敬凯,刘美,肇丽梅.他汀类药物在治疗慢性阻塞性肺疾病中的 作用[J].药学服务与研究,2015,15(3):166-170.
[6] 张静,查兆煜,王春艳.辛伐他汀治疗慢性阻塞性肺疾病合并肺动 脉高压患者的Meta 分析[J].贵州医药,2016,40(3):282-284.